Ingevity Corporation NGVT R2K

Q: What is the current share price of Ingevity Corporation (NGVT)?

As of 2026-07-15 16:51 PDT, Ingevity Corporation (NGVT) trades at $74.51 on NYSE. Its 52-week range is $40.40 to $77.87.

Q: What is the market capitalisation of NGVT?

Ingevity Corporation (NGVT) has a market capitalisation of $2.59B on NYSE.

Q: What is the P/E ratio of NGVT?

NGVT trades at a trailing price-to-earnings (P/E) ratio of -17.37. The industry average P/E is 23.08. Its price-to-book (P/B) ratio is 67.38.

Q: What is the return on equity (ROE) of NGVT?

NGVT has a return on equity (ROE) of -114.08%. Its return on capital employed (ROCE) is 31.97%.

Q: Is NGVT a good stock to buy?

This page provides a data-driven analysis of Ingevity Corporation (NGVT), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Basic Materials · Specialty Chemicals · United States

https://www.ingevity.com

Company Profile ↓

$74.51

+58.20% 1Y

Mkt Cap$2.59B

P/E-17.37

P/B67.38

52W High$77.87

52W Low$40.40

Book Value$1.11

EPS (TTM)$-4.29

Company Overview

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats. This segment also produces other activated carbon products for food, water, beverage, and chemical purification applications. The Performance Chemicals segment consists of road technologies and industrial specialties. This segment's products are used in pavement construction, pavement preservation, pavement reconstruction and recycling, road markings, agrochemical dispersants, lubricants, certain adhesives, rubber, and other industrial uses. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices. It serves automotive parts manufacturers through sales representatives, third-party sales representatives, and distributors. The company was formerly known as WestRock Company, Specialty Chemicals Business and changed its name to Ingevity Corporation in September 2015. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.

Why Investors Should Care

Healthy Capital Returns

Return on capital employed stands at 32.0%.

Healthy Margins

Operating margin of 26.7% supports profitability.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

Dec 2025 Revenue of $1.17B (-2.7% YoY); net profit $-167.10M.
Trailing 12 Months Year-on-year growth — revenue +4.1%, earnings +199.0%.
5-Year Trend Long-term compounding — revenue CAGR 1.1%.

Growth & Price Performance

Compounded Sales Growth

5 Years:	1.10%
1 Year:	4.10%

Compounded Profit Growth

5 Years:	-
1 Year:	199.00%

Stock Price Performance

1 Year:	+58.20%
6 Months:	+13.63%
3 Months:	-2.68%
1 Month:	+3.51%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish

52-Week Range 91% of range

$40.40 $77.87

Trend Signals

Price vs 50-DMAAbove
Price vs 200-DMAAbove
RSI (14)57.50 · Neutral

Price Performance

1M+3.51%

3M-2.68%

6M+13.63%

1Y+58.20%

Auto-generated from price history and fundamentals; not investment advice.

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Period: Metric:

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

Healthy ROCE of 32.0%.
Generates positive free cash flow.
In a confirmed uptrend (50-DMA above 200-DMA).

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

Valuation

Stock P/E

-17.37

Industry PE

23.08

Forward P/E

12.54

PEG Ratio

2.41

Book Value

$1.11

Price to Book

67.38

P/S

2.22

EV/EBITDA

10.22

Dividend Yield

0.00%

Growth (CAGR)

Revenue 5Y

1.10%

Profit 5Y

Revenue (YoY)

4.10%

Earnings (YoY)

199.00%

Profitability & Returns

ROCE

31.97%

ROE

-114.08%

ROA

9.03%

Profit Margin

-10.85%

Op Margin

26.74%

Gross Margin

39.57%

EPS (Latest Qtr)

$1.66

EPS (TTM)

$-4.29

Balance Sheet & Liquidity

Debt/Equity

Quick Ratio

0.62

Current Ratio

1.42

Debt

$1.24B

Total Assets

$1.65B

Current Assets

Working Capital

Ownership

Promoter Holding

0.82%

Chg in Prom Hold

0.00%

FII / Inst Holding

106.71%

Chg in FII Hold

0.01%

Financial Snapshot

Enterprise Value

$2.59B

Total Revenue (TTM)

$1.18B

EBITDA

$360.60M

Free Cash Flow

$225.80M

Operating Cash Flow

$303.80M

Shares Outstanding

34.77M

Gross Margin

39.57%

Payout Ratio

0.00%

Peer comparison

Peer companies in the same sector (Basic Materials).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	NGVT Ingevity Corporation R2K	74.51	-17.37	$2.59B	0.00%	31.97%	-114.08%	1.10%	-
2	LIN Linde plc NDXSPX	514.15	34.05	$237.72B	1.22%	12.46%	18.23%	13.90%	18.47%
3	NEM Newmont Corporation SPX	95.21	12.35	$101.64B	1.10%	-	25.83%	6.53%	20.15%
4	FCX Freeport-McMoRan Inc. SPX	60.97	32.26	$87.65B	0.97%	12.50%	15.63%	1.35%	-1.26%
5	SHW The Sherwin-Williams Company SPX	332.29	31.92	$81.95B	0.97%	21.93%	60.72%	6.18%	8.26%
6	ECL Ecolab Inc. SPX	270.25	36.57	$76.06B	1.07%	14.29%	22.43%	6.17%	9.18%
7	CRH CRH plc SPX	103.96	19.04	$69.47B	1.52%	10.97%	15.81%	6.41%	9.30%
8	APD Air Products and Chemicals, Inc. SPX	293.69	30.98	$65.40B	2.40%	-0.62%	12.35%	-1.77%	-39.16%
9	CTVA Corteva, Inc. SPX	84.45	46.15	$56.48B	0.84%	-	5.14%	2.86%	9.94%

Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric	Mar 2015	Jun 2015	Sep 2015	Dec 2015	Mar 2016	Jun 2016	Sep 2016	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Mar 2026
Revenue	-	-	-	-	-	-	-	-	218.50M	260.30M	264.10M	229.50M	235.20M	308.60M	311.20M	278.60M	276.80M	352.80M	359.90M	303.40M	288.20M	270.60M	331.70M	325.60M	320.30M	358.40M	376.80M	382.80M	419.90M	482.00M	392.60M	481.80M	446.00M	340.10M	390.60M	333.80M	247.90M	365.10M	333.10M	258.00M
Gross Profit	67.10M	82.10M	76.90M	49.30M	63.00M	74.70M	80.40M	56.30M	70.70M	89.80M	93.20M	75.30M	85.10M	115.50M	118.60M	97.60M	97.10M	134.40M	139.50M	111.00M	114.60M	83.90M	139.60M	127.40M	126.20M	139.80M	141.80M	137.80M	150.60M	176.30M	130.40M	153.00M	129.00M	99.70M	123.20M	131.60M	111.90M	137.90M	133.90M	116.40M
Operating Income	41.70M	52.40M	50.70M	-	39.30M	49.20M	49.50M	-	39.90M	57.10M	62.70M	-	67.10M	89.40M	90.70M	-	83.50M	108.30M	114.00M	-	92.20M	67.20M	127.60M	-	105.40M	117.70M	119.50M	119.00M	121.10M	138.20M	103.90M	120.70M	110.40M	76.90M	101.30M	110.20M	-	-	-	-
Net Income	22.00M	25.30M	23.80M	8.60M	9.20M	24.10M	-7.20M	9.10M	19.00M	32.10M	33.80M	41.60M	30.80M	46.70M	49.50M	42.10M	22.70M	56.80M	59.90M	44.30M	45.30M	20.20M	69.90M	-	48.70M	44.30M	-4.20M	60.80M	59.80M	75.40M	50.70M	35.50M	25.20M	-56.00M	-283.70M	-107.20M	20.50M	-146.50M	43.50M	59.80M
Diluted EPS	0.52	0.60	0.57	0.20	0.22	0.57	-0.17	0.22	0.45	0.76	0.79	0.97	0.72	1.10	1.16	0.99	0.54	1.34	1.41	1.05	1.08	0.49	1.69	1.11	1.20	1.10	-0.11	1.55	1.54	1.98	1.35	0.97	0.69	-1.54	-7.81	-2.94	0.56	-4.02	1.18	1.66
R&D Expense	-	-	-	-	4.60M	4.60M	3.90M	-	5.10M	4.70M	4.80M	-	5.00M	5.30M	5.60M	-	5.10M	5.00M	4.90M	-	6.20M	5.40M	5.20M	-	6.60M	5.90M	6.80M	7.30M	8.20M	7.60M	8.80M	8.00M	7.80M	6.80M	7.30M	6.20M	7.00M	7.80M	7.00M	6.70M

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	1.04B	958.30M	908.30M	972.40M	1.13B	1.29B	1.22B	1.39B	1.67B	1.22B	1.20B	1.17B
Gross Profit	318.50M	275.40M	274.40M	329.00M	416.80M	482.00M	465.50M	512.80M	570.10M	445.00M	464.80M	461.50M
Operating Income	213.30M	166.30M	163.60M	242.70M	320.50M	396.90M	397.90M	422.20M	452.60M	423.20M	425.90M	418.70M
Net Income	129.00M	79.70M	35.20M	126.50M	169.10M	183.70M	181.40M	118.10M	211.60M	-5.40M	-430.30M	-167.10M
Diluted EPS	3.06	1.89	0.83	2.97	3.97	4.35	4.37	2.95	5.50	-0.15	-11.85	-4.61
R&D Expense	7.80M	17.40M	17.60M	19.80M	21.50M	19.70M	22.60M	26.30M	30.30M	25.40M	24.50M	28.40M

Balance Sheet (Annual)

Figures in USD.

Metric	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	717.30M	778.70M	832.80M	929.60M	1.32B	2.14B	2.33B	2.47B	2.74B	2.62B	2.02B	1.65B
Total Equity	326.30M	416.60M	513.60M	127.00M	263.90M	338.70M	530.80M	642.10M	673.80M	698.30M	631.40M	195.20M	29.70M
Cash & Equivalents	11.50M	19.90M	32.00M	30.50M	87.90M	77.50M	56.50M	257.70M	275.40M	76.70M	95.90M	68.00M	78.10M
Total Liabilities	-	-	261.30M	698.20M	651.70M	976.50M	1.61B	1.69B	1.80B	2.04B	1.99B	1.83B	1.62B
Current Liabilities	-	-	99.80M	136.90M	153.20M	183.30M	215.50M	223.40M	268.90M	303.50M	362.90M	264.10M	341.30M

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	138.50M	72.20M	127.90M	174.30M	252.00M	275.70M	352.40M	293.30M	313.40M	205.10M	128.60M	331.20M
Investing Cash Flow	-96.80M	-89.30M	-126.40M	-58.60M	-414.40M	-658.30M	-110.60M	-138.60M	-551.90M	-77.30M	-79.50M	-57.50M
Financing Cash Flow	-31.70M	27.00M	-3.40M	-57.80M	153.70M	369.20M	-50.20M	-133.10M	48.10M	-99.90M	-70.20M	-252.20M
Capital Expenditure	-	-	-	-	-93.90M	-114.80M	-82.10M	-	-	-	-	-
Free Cash Flow	-	-	-	-	158.10M	160.90M	270.30M	-	-	-	-	-
Share Buybacks	-	0	0	6.60M	47.40M	6.40M	88.00M	109.40M	145.20M	92.10M	0	56.30M

Ratios (Annual)

Figures in %.

Metric	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	30.8%	28.7%	30.2%	33.8%	36.8%	37.3%	38.3%	36.9%	34.2%	36.6%	38.7%	39.5%
Operating Margin %	20.6%	17.4%	18.0%	25.0%	28.3%	30.7%	32.7%	30.3%	27.1%	34.8%	35.5%	35.9%
Net Margin %	12.5%	8.3%	3.9%	13.0%	14.9%	14.2%	14.9%	8.5%	12.7%	-0.4%	-35.9%	-14.3%
ROE %	31.0%	15.5%	27.7%	47.9%	49.9%	34.6%	28.3%	17.5%	30.3%	-0.9%	-220.4%	-562.6%
ROCE %	-	24.5%	23.5%	31.3%	28.3%	20.6%	18.8%	19.2%	18.6%	18.7%	24.2%	32.0%

Shareholding Pattern

Insiders

0.82%

Institutions

106.71%

Public Float

107.59%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	Blackrock Inc.	15.24%	5.30M	$397.99M
2	Vanguard Portfolio Management LLC	6.26%	2.18M	$163.53M
3	Vanguard Capital Management LLC	4.55%	1.58M	$118.84M
4	Wellington Management Group, LLP	4.30%	1.49M	$112.26M
5	State Street Corporation	4.20%	1.46M	$109.63M
6	American Century Companies Inc	4.12%	1.43M	$107.62M
7	Millennium Management Llc	3.32%	1.16M	$86.80M
8	Segall Bryant & Hamill, LLC	3.19%	1.11M	$83.32M
9	Brown Advisory Inc.	2.85%	992.02K	$74.53M
10	Simcoe Capital Management, LLC	2.82%	982.01K	$73.77M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for NGVT

Google News ue, 07 Jul 2026

Ingevity Shares Rise 25% YTD: Can the Stock Sustain the Rally? - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxNWWhOYmhFRUg1Wm1zZS1fZDZudU5FS0tTVTZqekRMTDJSRGdLSlF6eDBzSU41MjQ4VG10bjdXc2c5dzZHQk51R04tZ3QtSzJSc3JjeGVtWUhPQTBndkl4VlZKQ005T3p3NXYyemU3NGFRbUh4eURSRjFfRklNVF9ubmRzZWhIYV82bjBzWW…

Google News hu, 02 Jul 2026

Ingevity schedules July 29 earnings release, July 30 webcast - Stock Titan

<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxPS3Y4VkpNNDhPbjhucnZIcEY1X096bFpPdjhHV0FKenRJMVE3NzFxelZuZkpnTFdyVk5wdURJV21pMmxzWWxFcUYweVUxZnlycnkzbXhFaXk1QTZ4QWs3OUhSSFRyMlFuTmxEMy1GdWFab3ZkRS1rVHZOTUwzWnNtTG5SVmFnak1qZHZtcl…

Google News Mon, 01 Jun 2026

Insider Sale: SVP of $NGVT Sells 266 Shares | NGVT Stock News - Quiver Quantitative

<a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxNWkxWTUhOR1h4bHFCTFpDSkw0YV9ZNFlYNzZVRG5BVXNvYVh2SV9hUGJpS2l5N2JJWS1kSk5kNmZBOUU0RHNBZW4tclZzZ1o2NU02c08tVnFGX3c2Z2FyMUR4WW5ZWU1qQUpoRUxnTjNiX2tPcDVoazlmUzd2U3dvR2tSTm5CbWc?oc=5" …

Google News Fri, 26 Jun 2026

Is Ingevity (NGVT) Undervalued Or Is Its Recovery Story Already Priced In? - simplywall.st

<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxPaE9wTW1yWFcwQzh1T2VGWTZjUGxjcmY3ck5nNzY0ZTM5c1lTdzBzVmtBcHdGNndnUW9tcTU1VkhPQnlPVEx2SV9fcTFsRngybkxCd1JBYVJYeW1aajdZZlVuN1I0Wkp4aGFlQjJDMDNmdnhSV21UUWpjZzBESkJINjMzZ3o1UFJ1OFdPZz…

Google News hu, 25 Jun 2026

Ingevity Appoints Ryan Cotterman As Chief Accounting Officer - The Globe and Mail

<a href="https://news.google.com/rss/articles/CBMi2gFBVV95cUxOUHY2NnNKMTFmWUh4aXdfXzh1ejAwN2dJanctWk9NZXpLbkxUOU9OdHVSZ2FqTXN5MjJ3T1lmM3pJMFQzeThmZ2d4MkVaX1BiLXVVQ2lrUFBSOGRDcTZQazI1bXhEcWlGcWJNQi1FNzFMZVJVcWZiSm9FQ2FUTFVDa3licFoxaWE2c3cyWk…

Google News hu, 09 Jul 2026

How Ingevity Corporation (NGVT) Affects Rotational Strategy Timing - Stock Traders Daily

<a href="https://news.google.com/rss/articles/CBMi3AFBVV95cUxNU3ctQ3g2QUNibjJjeDRsdk01U0pyTkJzdDZGMjFoSVFtSF96YXRwaC1PWmtsVUlYclo3ZkFyWHBsbnFkalh2bktaZFFWTW5VX3psQVZsUnpSVXVmNEg5QjdYdHJqMk9EMEthcGJKdkVvVmhaZEFnOXJsblRwaE8xVnJtVTZpYUltUzZKek…

NGVT — Frequently Asked Questions

What is the current share price of Ingevity Corporation (NGVT)?

As of 2026-07-15 16:51 PDT, Ingevity Corporation (NGVT) trades at $74.51 on NYSE. Its 52-week range is $40.40 to $77.87.

What is the market capitalisation of NGVT?

Ingevity Corporation (NGVT) has a market capitalisation of $2.59B on NYSE.

What is the P/E ratio of NGVT?

NGVT trades at a trailing price-to-earnings (P/E) ratio of -17.37. The industry average P/E is 23.08. Its price-to-book (P/B) ratio is 67.38.

What is the return on equity (ROE) of NGVT?

NGVT has a return on equity (ROE) of -114.08%. Its return on capital employed (ROCE) is 31.97%.

Is NGVT a good stock to buy?

This page provides a data-driven analysis of Ingevity Corporation (NGVT), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Basic Materials Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks

Ingevity Corporation NGVT R2K

Company Overview

Why Investors Should Care

Recent Developments

Growth & Price Performance

Compounded Sales Growth

Compounded Profit Growth

Stock Price Performance

Price Chart

Technical Trend

Fundamental Growth Charts

PROS

CONS

Valuation

Growth (CAGR)

Profitability & Returns

Balance Sheet & Liquidity

Ownership

Financial Snapshot

Peer comparison

Quarterly Results

Profit & Loss (Annual)

Balance Sheet (Annual)

Cash Flows (Annual)

Ratios (Annual)

Shareholding Pattern

Top Institutional Holders

Analyst View

Latest News

Ingevity Shares Rise 25% YTD: Can the Stock Sustain the Rally? - Yahoo Finance

Ingevity schedules July 29 earnings release, July 30 webcast - Stock Titan

Insider Sale: SVP of $NGVT Sells 266 Shares | NGVT Stock News - Quiver Quantitative

Is Ingevity (NGVT) Undervalued Or Is Its Recovery Story Already Priced In? - simplywall.st

Ingevity Appoints Ryan Cotterman As Chief Accounting Officer - The Globe and Mail

How Ingevity Corporation (NGVT) Affects Rotational Strategy Timing - Stock Traders Daily

NGVT — Frequently Asked Questions

What is the current share price of Ingevity Corporation (NGVT)?

What is the market capitalisation of NGVT?

What is the P/E ratio of NGVT?

What is the return on equity (ROE) of NGVT?

Is NGVT a good stock to buy?

Explore More